Ethical Investment in Global Health Security

October 12, 2018: Health Policy and Bioethics Consortium
12:30 - 2 p.m.
25 Shattuck Street, Gordan Hall, Waterhouse Room

Health emergencies around the world in recent years have included SARS, MERS, Ebola, and influenza. These episodes have led to substantial mortality, destabilize governments, and serve as significant risks to economic stability and development. So what steps can we take to enhance global health security? What are the ethical considerations in responding to global pandemics?


Vanessa B. Kerry, MD, MSc
Associate Professor of Medicine, Harvard Medical School
Chief Exectuive Officer, Seed Global Health

Lawrence O. Gostin, JD
Linda D. & Timothy J. O'Neill Professor of Global Health
Georgetown Law School


Register here

This event is free and open to the public, but registration is required. 

The Health Policy and Bioethics Consortia is a monthly series that convenes two international experts from different fields or vantage points to discuss how biomedical innovation and health care delivery are affected by various ethical norms, laws, and regulations. They are organized by the Center for Bioethics at Harvard Medical School and the Program On Regulation, Therapeutics, And Law (PORTAL) at Brigham and Women's Hospital, in collaboration with the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. Support provided by the Oswald DeN. Cammann Fund at Harvard University.